These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24096604)

  • 41. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
    Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
    Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs.
    Fourie LJ; Du Rand C; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880
    [No Abstract]   [Full Text] [Related]  

  • 43. Feline Advantage Heart (imidacloprid and moxidectin) topical solution as monthly treatment for prevention of heartworm infection (Dirofilaria immitis) and control of fleas (Ctenocephalides felis) on cats.
    Arther RG; Bowmann DD; McCall JW; Hansen O; Young DR
    Parasitol Res; 2003 Jul; 90 Suppl 3():S137-9. PubMed ID: 12928881
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal.
    Otranto D; Colella V; Bezerra-Santos MA; Mendoza-Roldan JA; Cavalera MA; Pereira A; Schaper R; Maia C
    Parasit Vectors; 2021 Apr; 14(1):199. PubMed ID: 33849643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
    Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
    Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations.
    Krüdewagen EM; Remer C; Deuster K; Schunack B; Wolken S; Crafford D; Fourie J; Stanneck D
    Parasitol Res; 2015 Aug; 114 Suppl 1():S55-80. PubMed ID: 26152409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R
    Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dirofilaria infections in dogs in different areas of Greece.
    Diakou A; Kapantaidakis E; Tamvakis A; Giannakis V; Strus N
    Parasit Vectors; 2016 Sep; 9(1):508. PubMed ID: 27646111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi).
    Le Sueur C; Bour S; Schaper R
    Parasitol Res; 2010 Nov; 107(6):1463-9. PubMed ID: 20706736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
    Kryda K; Holzmer S; Everett WR; McCall JW; Mahabir SP; McTier TL; Maeder SJ
    Parasit Vectors; 2020 Jul; 13(1):339. PubMed ID: 32660542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pilot trial evaluating the efficacy of a 10% imidacloprid/2.5% moxidectin spot-on formulation in the treatment of natural nasal capillariosis in dogs.
    Veronesi F; Morganti G; Di Cesare A; Schaper R; Traversa D
    Vet Parasitol; 2014 Feb; 200(1-2):133-8. PubMed ID: 24365240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphometric analyses of canine blood microfilariae isolated by the Knott's test enables Dirofilaria immitis and D. repens species-specific and Acanthocheilonema (syn. Dipetalonema) genus-specific diagnosis.
    Magnis J; Lorentz S; Guardone L; Grimm F; Magi M; Naucke TJ; Deplazes P
    Parasit Vectors; 2013 Feb; 6():48. PubMed ID: 23442771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vector-borne parasitic infections in dogs in the Baltic and Nordic countries: A questionnaire study to veterinarians on canine babesiosis and infections with Dirofilaria immitis and Dirofilaria repens.
    Tiškina V; Jokelainen P
    Vet Parasitol; 2017 Sep; 244():7-11. PubMed ID: 28917320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of imported canine filarial infections in Germany 2008 - 2010.
    Pantchev N; Etzold M; Daugschies A; Dyachenko V
    Parasitol Res; 2011 Aug; 109 Suppl 1():S61-76. PubMed ID: 21739376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of a single topical application of Advantage Multi (= Advocate) Topical Solution (10% imidocloprid + 2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis.
    Conboy G; Hare J; Charles S; Settje T; Heine J
    Parasitol Res; 2009 Aug; 105 Suppl 1():S49-54. PubMed ID: 19575225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
    Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
    Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in Europe.
    Hellmann K; Knoppe T; Radeloff I; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S142-3. PubMed ID: 12928883
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
    Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
    Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis.
    Blagburn BL; Arther RG; Dillon AR; Butler JM; Bowles JV; von Simson C; Zolynas R
    Parasit Vectors; 2016 Apr; 9():191. PubMed ID: 27044379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study.
    Becskei C; Cuppens O; Mahabir SP
    Vet Dermatol; 2018 Jun; 29(3):203-e72. PubMed ID: 29423956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.